Substance / Medication

Sulfanilamide

Overview

Active Ingredient
sulfanilamide
RxNorm CUI
10184

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
A technique based on infrared spectroscopy for determining sulfanilamide levels sustainably: Progress and comparisons of greenness and whiteness using ComplexGAPI, AGREE, and RGB.
Lahkar Chintu, Ansary Akramul, Kashyap Manoj et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2024
PMID: 38796892Observational
Oral absorption profiles of sulfonamides in Shiba goats: a comparison among sulfadimidine, sulfadiazine and sulfanilamide.
Elbadawy Mohamed, Ishihara Yusuke, Aboubakr Mohamed et al. · J Vet Med Sci · 2016
PMID: 27010464ObservationalFull text (PMC)
Methemoglobinemia induced by topical vaginal sulfanilamide cream in a patient with cervical cancer: a case report.
Bristol Ian, Brown Jubilee, Slomovitz Brian M et al. · Gynecol Oncol · 2005
PMID: 15907987Case Report
Quantum chemical and in silico-driven structural refinement of sulfanilamide for improved efficacy and safety.
Sultana Sadia, Shuvo Mahmudul Hasan, Zaman Fahmida et al. · In Silico Pharmacol · 2026
PMID: 41527580OtherFull text (PMC)
Benzo-α-pyrone-derived multitargeting actions to enhance the antibacterial performance of sulfanilamides against Escherichia coli.
Wang Yi-Xin, Wang Hao-Ran, Zhao Jiang-Sheng et al. · Bioorg Chem · 2025
PMID: 40056605Other
Design and synthesis of novel sulfanilamide derivatives as aminopeptidase N inhibitors.
Zhu Hong, Zhang Xiaoyan, Zhang Baojun et al. · Bioorg Med Chem Lett · 2025
PMID: 40280449Other
The impact of microplastic and sulfanilamide co-exposure on soil microbiota.
Shen Weishou, Wu Yang, Li Futao et al. · Ecotoxicol Environ Saf · 2025
PMID: 40022827Other
Discovery of Sulfanilamide-diazo Derivatives Incorporating Benzoic Acid Moieties as Novel Inhibitors of Human Carbonic Anhydrase II Activity.
Belani Farshid, Mehrabi Maryam, Adibi Hadi et al. · Curr Protein Pept Sci · 2025
PMID: 39648421Other
Identification of new 1,2,3-Triazole analogues of sulfanilamide as inhibitors of the carbonic anhydrase II enzyme: Comprehensive in-vitro and in-vivo analyses.
Malik Aqsa, Huda Noor Ul, Tahir Syeda Sarah et al. · Int J Biol Macromol · 2025
PMID: 39894100Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sulfanilamide (substance)
SNOMED CT
56436005
UMLS CUI
C0038702
RxNorm CUI
10184

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.